Equivariant Graph Attention Networks with Structural Motifs for Predicting Cell Line-Specific Synergistic Drug Combinations

• URL: http://arxiv.org/abs/2411.04747v1
• Date: Thu, 07 Nov 2024 14:29:05 GMT
• Title: Equivariant Graph Attention Networks with Structural Motifs for Predicting Cell Line-Specific Synergistic Drug Combinations
• Authors: Zachary Schwehr,
• Abstract summary: Cancer is the second leading cause of death, with chemotherapy as one of the primary forms of treatment. Current methods of drug combination screening, such as in vivo and in vitro, are inefficient due to stark time and monetary costs. I employ a geometric deep-learning model utilizing a graph attention network that is equivariant to 3D rotations, translations, and reflections with structural motifs.
• Score: 0.0
• License:
• Abstract: Cancer is the second leading cause of death, with chemotherapy as one of the primary forms of treatment. As a result, researchers are turning to drug combination therapy to decrease drug resistance and increase efficacy. Current methods of drug combination screening, such as in vivo and in vitro, are inefficient due to stark time and monetary costs. In silico methods have become increasingly important for screening drugs, but current methods are inaccurate and generalize poorly to unseen anticancer drugs. In this paper, I employ a geometric deep-learning model utilizing a graph attention network that is equivariant to 3D rotations, translations, and reflections with structural motifs. Additionally, the gene expression of cancer cell lines is utilized to classify synergistic drug combinations specific to each cell line. I compared the proposed geometric deep learning framework to current state-of-the-art (SOTA) methods, and the proposed model architecture achieved greater performance on all 12 benchmark tasks performed on the DrugComb dataset. Specifically, the proposed framework outperformed other SOTA methods by an accuracy difference greater than 28%. Based on these results, I believe that the equivariant graph attention network's capability of learning geometric data accounts for the large performance improvements. The model's ability to generalize to foreign drugs is thought to be due to the structural motifs providing a better representation of the molecule. Overall, I believe that the proposed equivariant geometric deep learning framework serves as an effective tool for virtually screening anticancer drug combinations for further validation in a wet lab environment. The code for this work is made available online at: https://github.com/WeToTheMoon/EGAT_DrugSynergy.

Related papers

• Benchmark on Drug Target Interaction Modeling from a Structure Perspective [48.60648369785105]
  Drug-target interaction prediction is crucial to drug discovery and design. Recent methods, such as those based on graph neural networks (GNNs) and Transformers, demonstrate exceptional performance across various datasets. We conduct a comprehensive survey and benchmark for drug-target interaction modeling from a structure perspective, via integrating tens of explicit (i.e., GNN-based) and implicit (i.e., Transformer-based) structure learning algorithms.
  arXiv  Detail & Related papers  (2024-07-04T16:56:59Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• ALNSynergy: a graph convolutional network with multi-representation alignment for drug synergy prediction [8.316187397380244]
  Drug combination refers to the use of two or more drugs to treat a specific disease at the same time. In this work, we propose ALNSynergy, a graph convolutional network with multi-representation alignment for predicting drug synergy.
  arXiv  Detail & Related papers  (2023-11-27T15:34:14Z)
• Precision Anti-Cancer Drug Selection via Neural Ranking [0.342658286826597]
  We propose two neural listwise ranking methods that learn latent representations of drugs and cell lines, and then use those representations to score drugs in each cell line via a learnable scoring function. Our results demonstrate that List-All outperforms the best baseline with significant improvements of as much as 8.6% in hit@20 across 50% test cell lines.
  arXiv  Detail & Related papers  (2023-06-30T16:23:25Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction [127.43571146741984]
  Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery. wet experiments remain the most reliable method, but they are time-consuming and resource-intensive. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
  arXiv  Detail & Related papers  (2022-06-20T14:53:25Z)
• MOOMIN: Deep Molecular Omics Network for Anti-Cancer Drug Combination Therapy [2.446672595462589]
  We propose a multimodal graph neural network that can predict the synergistic effect of drug combinations for cancer treatment. Our model captures the representation based on the context of drugs at multiple scales based on a drug-protein interaction network and metadata. We demonstrate that the model makes high-quality predictions over a wide range of cancer cell line tissues.
  arXiv  Detail & Related papers  (2021-10-28T13:10:25Z)
• DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations [0.9854322576538699]
  computational screening has become an important way to prioritize drug combinations. DeepDDS was superior to competitive methods by more than 16% predictive precision.
  arXiv  Detail & Related papers  (2021-07-06T08:25:43Z)
• Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response [49.86828302591469]
  In this paper, we apply transfer learning to the prediction of anti-cancer drug response. We apply the classic transfer learning framework that trains a prediction model on the source dataset and refines it on the target dataset. The ensemble transfer learning pipeline is implemented using LightGBM and two deep neural network (DNN) models with different architectures.
  arXiv  Detail & Related papers  (2020-05-13T20:29:48Z)
• A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning [49.86828302591469]
  We train >35,000 neural network models, sweeping over common featurization techniques. We found the RNA-seq to be highly redundant and informative even with subsets larger than 128 features.
  arXiv  Detail & Related papers  (2020-04-30T20:42:17Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.